Patent · US Active

Pyrimidine compounds

US7589197B2 · kind B2 · utility

7Cited by
3References
8Claims
0Family size

Assignee

Inventors

Key dates

Filing dateJun 13, 2006
Grant dateSep 15, 2009
Priority date
Expiry dateMay 30, 2027

Classification

  • Technology area (CPC C)Chemistry; Metallurgy
  • CPC primaryC07D405/12
  • WIPO fieldPharmaceuticals
  • WIPO sectorChemistry

Abstract

This invention relates to a method for treating inflammatory diseases or immune diseases, developmental or degenerative diseases, or tissue injuries. The method includes administering to a subject in need thereof an effective amount of one or more compounds of formula (I). Each variable in this formula is defined in the specification.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.